TAZTIA XT Drug Patent Profile
✉ Email this page to a colleague
When do Taztia Xt patents expire, and when can generic versions of Taztia Xt launch?
Taztia Xt is a drug marketed by Actavis Labs Fl Inc and is included in one NDA.
The generic ingredient in TAZTIA XT is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Taztia Xt
A generic version of TAZTIA XT was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAZTIA XT?
- What are the global sales for TAZTIA XT?
- What is Average Wholesale Price for TAZTIA XT?
Summary for TAZTIA XT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Patent Applications: | 2,870 |
| Drug Prices: | Drug price information for TAZTIA XT |
| DailyMed Link: | TAZTIA XT at DailyMed |
US Patents and Regulatory Information for TAZTIA XT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-001 | Apr 10, 2003 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-004 | Apr 10, 2003 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-002 | Apr 10, 2003 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
